retatrutide trial results π may be redefining obesity treatment. New data from TRIUMPH-1 showed: π₯ ~28% average weight loss over 80 weeks π₯ >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide Results: 28.3% Weight Loss
Description
24.2% weight loss at 48 weeks (Phase 2)

A 52-year-old man with long-standing type 2 diabetes mellitus (T2DM), obesity (BMI 36 kg/m), and hypertension was followed in a primary care clinic for suboptimal glycemic control

Noom's microdose program uses 0.1-0.6mg doses (up to 25% of standard maintenance) combined with behavioral coaching
in 1995it has consistently shown benefits beyond glycemic control, including weight neutrality and potential cardioprotective effects (Bailey J in Diabetologia